Abstract:Background: Allergic drug reaction or drug allergy is an immunologically mediated drug hypersensitivity reaction (DHR). G-protein coupled receptors (GPCRs) are common drug targets and communicate extracellular signals that initiate cellular responses. Recent evidence shows that GPCR MRGPRX2 is of major importance in IgE-independent pseudo-allergic DHRs based on the suspected interactions between many FDA-approved peptidergic compounds and MRGPRX2. Objective: Our aim was to uncover novel MRGPRX2-selective and -potent agonists as drug candidates responsible for clinical features of pseudo-allergic DHRs. Methods: We conducted a primary high-throughput screening (HTS), coupled with mutagenesis targeting the MRGPRX2 N62S mutation, on a panel of 3,456 library compounds. We discovered pharmacologically active hit compounds as agonists of the MRGPRX2 protein according to high degrees of potency evaluated by the calcium response and validated by the degranulation assay. Using the molecular tool Forge, we also characterized the structure-activity relationship shared by identified hit compounds. Results: The alternative allele of single nucleotide polymorphism rs10833049 (N62S) in MRGPRX2 demonstrated loss-of-function property in response to substance P and antineoplastic agent daunorubicin hydrochloride. We applied a unique assay system targeting the N62S mutation to the HTS and identified 84 MRGPRX2-selective active hit compounds representing diverse classes according to primary drug indications. The top five highly represented groups included fluoroquinolone and non-fluoroquinolone antibiotics; antidepressive/antipsychotic; antihistaminic and antineoplastic agents. We classified hit compounds into 14 clusters representing a variety of chemical and drug classes beyond those reported, such as opioids, neuromuscular blocking agents, and fluoroquinolones. We further demonstrated MRGPRX2-dependent degranulation in the human mast cell line LAD2 cells induced by three novel agonists representing the non-fluoroquinolone antibiotics (bacitracin A), anti-allergic agents (brompheniramine maleate) and tyrosine-kinase inhibitors (imatinib mesylate). Conclusion: Our findings could facilitate the development of interventions for personalized prevention and treatment of DHRs, as well as future pharmacogenetic investigations of MRGPRX2 in relevant disease cohorts.

A Novel Human MrgX2-ELISA Kit to Detect MrgX2 Concentration Associated with Chronic Urticaria

A Novel ELISA Method to Determine Human MrgX2 in Chronic Urticaria

A Kind of IgE-Independent Chronic Urticarial Mediated by MRGPRX2

A Paper-Based ELISA for Rapid Sensitive Determination of Anaphylaxis-Related MRGPRX2 in Human Peripheral Blood

Establishment of Substance P Modified Affinity Chromatography for Specific Detection and Enrichment of Mas-related G Protein–coupled Receptor X2

Beyond Allergies—Updates on The Role of Mas-Related G-Protein-Coupled Receptor X2 in Chronic Urticaria and Atopic Dermatitis

Identification of Pyruvic and Maleic Acid As Potential Markers for Disease Activity and Prognosis in Chronic Urticaria

Development of an Environmentally Sensitive Fluorescent Peptide Probe for MrgX2 and Application in Ligand Screening of Peptide Antibiotics.

Serum miR-125a-5p and CCL17 Upregulated in Chronic Spontaneous Urticaria and Correlated with Treatment Response.

MrgX2-SNAP-tag/cell Membrane Chromatography Model Coupled with Liquid Chromatography-Mass Spectrometry for Anti-Pseudo-allergic Compound Screening in Arnebiae Radix.

Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis

Beyond the classic players: Mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases

Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists

Mast cell activation related molecules and antibodies in differentiating allergic skin diseases

Integrated Bioinformatics and Validation Reveal IL1B and Its Related Molecules as Potential Biomarkers in Chronic Spontaneous Urticaria

The Human Mast Cell Line-1 Cell Membrane Chromatography Coupled with HPLC-ESI-MS/MS Method for Screening Potentical Anaphylactic Components from Chuanxinlian Injection.

Expression of NMU and NMUR1 in tryptase-positive mast cells and PBLs in allergic rhinitis patients' nasal mucosa

Mast cell signaling and its role in urticaria

Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients

Detection and Significance of Serum Diamine Oxidase Activity and Total IgE in Chronic Urticaria Patients

Biological screening of a unique drug library targeting MRGPRX2